Company Filing History:
Years Active: 2015
Title: Mutsunori Tanji - Innovator in Enteric Coated Granules
Introduction
Mutsunori Tanji is a notable inventor based in Fukushima, Japan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of enteric coated granules. His innovative work focuses on enhancing the controlled dissolution of granules in water, which is crucial for effective drug delivery.
Latest Patents
Mutsunori Tanji holds a patent for an enteric coated granule and the method for preparing the same. This invention is designed to provide controlled dissolution in water, even with a minimal coating amount. The patent describes an enteric coated granule that includes a raw granule covered by at least one layer. The first enteric layer is made from a hydroxypropylmethyl cellulose acetate succinate (HPMCAS) that has a specific solubility pH. A second enteric layer, formed over the first, uses a different HPMCAS with a lower solubility pH value. This innovative approach allows for improved performance in drug delivery systems.
Career Highlights
Mutsunori Tanji is associated with Shin-Etsu Chemical Co., Ltd., where he has been able to apply his expertise in pharmaceutical formulations. His work has contributed to advancements in the field, particularly in the area of enteric coatings, which are essential for protecting sensitive compounds from degradation in the gastrointestinal tract.
Collaborations
Mutsunori Tanji has collaborated with notable colleagues such as Tadashi Matsui and Shuichiro Yuasa. These collaborations have likely fostered an environment of innovation and shared expertise, further enhancing the development of new pharmaceutical technologies.
Conclusion
Mutsunori Tanji's contributions to the field of enteric coated granules demonstrate his commitment to advancing pharmaceutical science. His innovative patent reflects a significant step forward in drug delivery systems, showcasing the importance of controlled dissolution in enhancing therapeutic efficacy.